SUSTAINED-RELEASE LOW-DOSE FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT FOR CHRONIC POSTOPERATIVE CYSTOID MACULAR EDEMA: TWO CASE REPORTS. [PDF]
Kiernan DF.
europepmc +1 more source
Safety and effectiveness of the fluocinolone acetonide intravitreal implant (ILUVIEN): 3-year results from the European IRISS registry study. [PDF]
Khoramnia R+8 more
europepmc +1 more source
Biomarkers to Predict the Success of Treatment with the Intravitreal 0.19 mg Fluocinolone Acetonide Implant in Uveitic Macular Edema. [PDF]
Kessler LJ+3 more
europepmc +1 more source
Fluocinolone acetonide 0.2 µg/day intravitreal implant in non-infectious uveitis affecting the posterior segment: EU expert user panel consensus-based clinical recommendations. [PDF]
Pleyer U+9 more
europepmc +1 more source
Efficacy of 0.19 mg Fluocinolone Acetonide Implant in Non-infectious Posterior Uveitis Evaluated as Area Under the Curve. [PDF]
Battista M+7 more
europepmc +1 more source
Correction: The outcome of fluocinolone acetonide intravitreal implant is predicted by the response to dexamethasone implant in diabetic macular oedema. [PDF]
Cicinelli MV+9 more
europepmc +1 more source
Role of Corticosteroids in Oral Lesions [PDF]
Mehdipour, Masoumeh, Zenouz, Ali Taghavi
core +1 more source
Migration of a Fluocinolone Acetonide Intravitreal Implant Into the Anterior Chamber
Li, Angela S.+2 more
openaire +3 more sources
Real-World Evidence of the Long-Term Effectiveness of 0.2 μg/Day Fluocinolone Acetonide Implant in Persistent and Recurrent Diabetic Macular Edema - A Single Center Study. [PDF]
Soares RM+7 more
europepmc +1 more source